RPID

Rapid Micro Biosystems, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-12

Figures on this page computed 2026-11-08 12:59 UTC

Last close

0.68USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-12

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-12
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-07
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-07
The filing itself
-140.3%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
-95.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
0.72Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-07
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.41 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.50x

0.97x

0.74x

1.90x

0.18x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-12

Sales1.50x
Its own average over 7 years, 22.4M.
Profit0.97x
Its own average over 7 years, -48.4M.
Free cash flow0.74x
Its own average over 7 years, -43.2M.
Debt1.90x
Its own average over 7 years, 12.6M.
Price0.18x
Its own average over 6 years, 4. Market data, 2026-11-04

Debt is furthest from its own average, at 1.90 times.

Sales is 1.50 times its own 7-year average; Profit is 0.97 times its own 7-year average; Free cash flow is 0.74 times its own 7-year average; Debt is 1.90 times its own 7-year average; Price is 0.18 times its own 6-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-12

Sales against its own 7-year average1.50
Source
filed
Statement
income
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
The filing itself
Profit against its own 7-year average0.97
Source
filed
Statement
income
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
The filing itself
Free cash flow against its own 7-year average0.74
Source
filed
Statement
income
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
The filing itself
Debt against its own 7-year average1.90
Source
filed
Statement
income
Fiscal year
2025
Accession
0001380106-26-000034
Reported in
USD
The filing itself
Price against its own 6-year average0.18Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD